5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol

C149H160Br6N25O12+ — CID 167698295

About 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol

5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol (PubChem CID 167698295) has the molecular formula C149H160Br6N25O12+ and a molecular weight of 2972.51 g/mol. Its IUPAC name is 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol.

Molecular Properties

• Compound Name: 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol
• PubChem CID: 167698295
• Molecular Formula: C149H160Br6N25O12+
• Molecular Weight: 2972.51 g/mol
• Exact Mass: 2964.78
• IUPAC Name: 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol
• SMILES: CC(C)CC[NH+](C)CCON=C1C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CC(CCON=C1C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21)Cc1ccccn1.CC1CCC(C(C)CCON=C2C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.CC1CCCN(CCON=C2C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)C1.CN(C)CCN(C)CCON=C1C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CN1CCC(N(C)CCON=C2C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1
• InChI: InChI=1S/C27H30BrN3O2.C26H23BrN4O2.C25H28BrN5O2.C24H25BrN4O2.C24H27BrN4O2.C23H26BrN5O2/c1-16-7-9-18(10-8-16)17(2)13-14-33-31-25-20-5-3-4-6-22(20)29-26(25)24-21-15-19(28)11-12-23(21)30-27(24)32;1-16(14-18-6-4-5-12-28-18)11-13-33-31-24-19-7-2-3-8-21(19)29-25(24)23-20-15-17(27)9-10-22(20)30-26(23)32;1-30-11-9-17(10-12-30)31(2)13-14-33-29-23-18-5-3-4-6-20(18)27-24(23)22-19-15-16(26)7-8-21(19)28-25(22)32;1-15-5-4-10-29(14-15)11-12-31-28-22-17-6-2-3-7-19(17)26-23(22)21-18-13-16(25)8-9-20(18)27-24(21)30;1-15(2)10-11-29(3)12-13-31-28-22-17-6-4-5-7-19(17)26-23(22)21-18-14-16(25)8-9-20(18)27-24(21)30;1-28(2)10-11-29(3)12-13-31-27-21-16-6-4-5-7-18(16)25-22(21)20-17-14-15(24)8-9-19(17)26-23(20)30/h3-6,11-12,15-18,30,32H,7-10,13-14H2,1-2H3;2-10,12,15-16,30,32H,11,13-14H2,1H3;3-8,15,17,28,32H,9-14H2,1-2H3;2-3,6-9,13,15,27,30H,4-5,10-12,14H2,1H3;4-9,14-15,27,30H,10-13H2,1-3H3;4-9,14,26,30H,10-13H2,1-3H3/p+1
• InChIKey: QAOGBEXAGWQTGM-UHFFFAOYSA-O
• XLogP: 31.28
• TPSA: 453.35 Ų
• H-Bond Donors: 13
• H-Bond Acceptors: 30
• Rotatable Bonds: 40
• Heavy Atoms: 192
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2972.51
LogP ≤ 5	31.28
H-Bond Donors ≤ 5	13
H-Bond Acceptors ≤ 10	30

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'imine_imine_A(9)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol?

The IUPAC name of 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol (CID 167698295) is 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol.

What is the SMILES notation for 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol?

The canonical SMILES for 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol is CC(C)CC[NH+](C)CCON=C1C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CC(CCON=C1C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21)Cc1ccccn1.CC1CCC(C(C)CCON=C2C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.CC1CCCN(CCON=C2C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)C1.CN(C)CCN(C)CCON=C1C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CN1CCC(N(C)CCON=C2C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.

What is the InChIKey of 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol?

The InChIKey is QAOGBEXAGWQTGM-UHFFFAOYSA-O. The full InChI is InChI=1S/C27H30BrN3O2.C26H23BrN4O2.C25H28BrN5O2.C24H25BrN4O2.C24H27BrN4O2.C23H26BrN5O2/c1-16-7-9-18(10-8-16)17(2)13-14-33-31-25-20-5-3-4-6-22(20)29-26(25)24-21-15-19(28)11-12-23(21)30-27(24)32;1-16(14-18-6-4-5-12-28-18)11-13-33-31-24-19-7-2-3-8-21(19)29-25(24)23-20-15-17(27)9-10-22(20)30-26(23)32;1-30-11-9-17(10-12-30)31(2)13-14-33-29-23-18-5-3-4-6-20(18)27-24(23)22-19-15-16(26)7-8-21(19)28-25(22)32;1-15-5-4-10-29(14-15)11-12-31-28-22-17-6-2-3-7-19(17)26-23(22)21-18-13-16(25)8-9-20(18)27-24(21)30;1-15(2)10-11-29(3)12-13-31-28-22-17-6-4-5-7-19(17)26-23(22)21-18-14-16(25)8-9-20(18)27-24(21)30;1-28(2)10-11-29(3)12-13-31-27-21-16-6-4-5-7-18(16)25-22(21)20-17-14-15(24)8-9-19(17)26-23(20)30/h3-6,11-12,15-18,30,32H,7-10,13-14H2,1-2H3;2-10,12,15-16,30,32H,11,13-14H2,1H3;3-8,15,17,28,32H,9-14H2,1-2H3;2-3,6-9,13,15,27,30H,4-5,10-12,14H2,1H3;4-9,14-15,27,30H,10-13H2,1-3H3;4-9,14,26,30H,10-13H2,1-3H3/p+1.

What are the key properties of 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol?

5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol has a molecular weight of 2972.51 g/mol, XLogP of 31.28, 40 rotatable bonds, 13 hydrogen bond donors, and 30 hydrogen bond acceptors.

Where does this data come from?

All data for 5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol is sourced from PubChem (CID 167698295), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).